News | May 8, 2026
A recent study by Tatyana Avilova, Economist at Secretariat has been selected by the Editor of JAMA Health Forum as an Editor’s Choice: Clinical Trial of 2025.
Managing Director Matt Farber provided trial testimony on behalf of SVV in patent litigation involving the infringement of patents covering optics and LED lighting technologies.
Secretariat was retained by Katz PLLC on behalf of SVV Technology Innovations Inc. in patent litigation alleging monitors sold by Taiwanese technology firm ASUSTek Computer Inc. infringed SVV patents covering optical film. Dr. Farber and Katz PLLC worked with Caldwell Cassady & Curry in the trial phase of the matter.
The September 26 verdict was reached after a four-day trial in the U.S. District Court for the Western District of Texas in Waco. The jury found that ASUSTek’s infringement of all claims of the four SVV patents was willful, and that ASUSTeK owed SVV $22,400,000 in damages, an amount based on Dr. Farber’s opinions.
Dr. Farber submitted an extensive report and testified at trial to his analysis and opinions regarding a reasonable royalty. Dr. Farber’s work was supported by Matt Fitzgerald, Alex Gisquet, and Jack Schwartz.
The patents involved are U.S. Patent Nos. 8,290,318, 9,880,342, 10,439,089, and 10,627,562. The case is SVV Technology Innovations Inc. v. ASUSTek Computer Inc., No. 6:22-cv-00311.
Law360 and Bloomberg Law (subscriptions may be required) coverage may be found here and here.